NCT03408028

Brief Summary

The diagnostic and therapeutic progresses, associated with modifications in lifestyle and socio-cultural level of populations, have led to a remarkable increase in life expectancy. At the same time, the increasing medicalization of the individual has eroded the traditional boundaries between health and illness, normal and pathological state. This leads to the patient losing his sense of ownership of his own death. If most patients died at home before the Second World War, 75% of the population dies in hospital or institution at the present date. Most hospitals and care institutions have developed codes, in multidisciplinary internal consultation, to address the interruption or lack of implementation of treatments that make no sense from a medical point of vue. This avoids therapeutic relentlessness.The code in place within the CHU Brugmann is:

  • code A: no therapeutic restriction
  • code B: not to be resuscitated
  • code C: not to be intensively treated (no escalation in therapeutic treatments)
  • code D: best palliative care (progressive de-escalation in therapeutic treatments). These codes are established in consultation with the patient or his legal representative and are re-evaluated in a multidisciplinary way every week. Planning a care path and therefore establishing a therapeutic code is particularly important for people with cognitive impairment and dementia because the progressive loss of cognitive abilities complicates the process of decision making. A large part of the admissions are made via the emergency department. For these patients, no therapeutic plan has been established beforehand. However, the perception of the functional and cognitive status of the patient directly influences the intensity of care provided. Cognitive disorders are a risk factor for the exclusion of access to palliative care for the elderly patient. The objectives of this study are:
  • To establish a record of the therapeutic limitation codes in an acute cognitive geriatric unit
  • To correlate the therapeutic limitation code with the comorbidities of the patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 23, 2018

Completed
Last Updated

January 23, 2018

Status Verified

January 1, 2018

Enrollment Period

6 months

First QC Date

January 17, 2018

Last Update Submit

January 17, 2018

Conditions

Cognitive Impairment

Keywords

Therapeutic codeGeriatry

Outcome Measures

Primary Outcomes (2)

  • Therapeutic code

    Therapeutic code

    From 01-01-2016 till 31-12-2016

  • Cumulative Illness Rating Scale for Geriatrics

    This scoring system measures the chronic medical illness ("morbidity") burden while taking into consideration the severity of chronic diseases in 14 items representing individual body systems. The cumulative final score can theoretically vary from 0 to 56.

    From 01-01-2016 till 31-12-2016

Secondary Outcomes (3)

  • Age

    From 01-01-2016 till 31-12-2016

  • Sex

    From 01-01-2016 till 31-12-2016

  • Ethnicity

    From 01-01-2016 till 31-12-2016

Study Arms (1)

Cognitive impairment

Geriatric patients with a cognitive impairment

Other: Medical File consultation

Interventions

Medical File consultationOTHER

Medical File consultation

Cognitive impairment

Eligibility Criteria

Age65 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eldelry patients with cognitive imparement admitted in the geriatric unit 83 within the CHU Brugmann between 01-01-2016 and 31-12-2016.

You may qualify if:

  • Elderly patients with cognitive impairment admitted in the geriatric unit 83 within the CHU Brugmann between 01-01-2016 and 31-12-2016.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Brugmann

Brussels, Belgium

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Carolina Natalia Grande Pérez, MD

    CHU Brugmann

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Clinic

Study Record Dates

First Submitted

January 17, 2018

First Posted

January 23, 2018

Study Start

April 1, 2017

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

January 23, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations

BE(1)